Search

Microbot Medical Inc

Slēgts

1.24 -1.59

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.23

Max

1.27

Galvenie mērījumi

By Trading Economics

Ienākumi

-2M

-5.6M

Pārdošana

136K

241K

EPS

-0.08

Peļņas marža

-2,334.855

Darbinieki

43

EBITDA

-1.9M

-5.6M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+396.73% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 10. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-39M

91M

Iepriekšējā atvēršanas cena

2.83

Iepriekšējā slēgšanas cena

1.24

Microbot Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 27. sept. 23:51 UTC

Australia's Inflation Rate Expected to Rise to 4.1% Amid Global Economic Pressures Ahead of September 30 Release

2026. g. 27. sept. 23:51 UTC

China's Non-Manufacturing PMI set for release on September 30, with forecasts indicating continued economic contraction at 49.3 amid cautious market sentiment and geopolitical concerns.

2026. g. 27. sept. 23:51 UTC

Australia's RBA Trimmed Mean CPI YoY data release on September 30, 2026, is crucial for understanding core inflation trends amid global economic uncertainties and potential interest rate impacts.

2026. g. 27. sept. 23:51 UTC

Australia's Building Permits Expected to Decline 0.9% in August Amid Mixed Trends and Economic Uncertainty

2026. g. 27. sept. 23:51 UTC

China's NBS Manufacturing PMI Set for Release on September 30, Forecasted at 50.1 Amid Concerns Over Economic Recovery and Global Trade Relations.

2026. g. 27. sept. 23:41 UTC

Bank of Japan to Release Key Monetary Policy Minutes Amid Optimism and Inflation Concerns on September 27, 2026

2026. g. 27. sept. 23:41 UTC

U.S. September 2026 Unemployment Rate Release Forecasts Slight Increase to 4.2%, Amid Cautious Market Sentiment and Economic Policy Discussions

2026. g. 27. sept. 23:41 UTC

U.S. Average Hourly Earnings Expected to Rise 0.3% in September, Influencing Fed's Rate Hike Decisions Amid Inflation Concerns

2026. g. 27. sept. 23:41 UTC

U.S. Non-Farm Payrolls Expected to Add 100K Jobs in September Amid Cautious Optimism and Potential Market Volatility

2026. g. 27. sept. 23:41 UTC

U.S. Labor Force Participation Rate Release on October 2, 2026, Expected Amidst Cautious Sentiment and Economic Challenges

2026. g. 27. sept. 23:41 UTC

US Average Hourly Earnings Report on October 2 Could Signal Fed Rate Hikes Amid Inflation Concerns and Market Volatility.

2026. g. 27. sept. 23:11 UTC

S&P Global Manufacturing PMI for South Korea Expected to Show Slight Decline Amid Economic Pressures and Resilient Industries

2026. g. 27. sept. 23:11 UTC

U.S. Home Prices Expected to Rise 2.2% YoY Amidst Stabilizing Market Sentiment Despite Inflation Pressures

2026. g. 27. sept. 23:11 UTC

Brazil's Industrial Production MoM Data Release on October 2, 2026: Market Anticipates Recovery Amid Ongoing Volatility.

2026. g. 27. sept. 23:11 UTC

The EUR/CZK is trading roughly flat at the start of the new week, showing little change since Friday's close and reflecting stable performance.

2026. g. 27. sept. 23:01 UTC

Correlated Moves
Macro News

The Russell 2000 Index is lower, continuing a decline from Friday's close, amid Boeing's software glitch concerns and ongoing U.S.-China tariff discussions.

2026. g. 27. sept. 23:01 UTC

Correlated Moves
Macro News

The Nasdaq 100 Index is trading modestly lower amid reports of a U.S.-China tariff agreement on $30 billion in goods and geopolitical concerns.

2026. g. 27. sept. 23:01 UTC

Macro News

The S&P 500 Index is trading lower amid macroeconomic developments, including the upcoming release of the Bank of Japan's July monetary policy minutes.

2026. g. 27. sept. 23:01 UTC

Correlated Moves
Macro News

Silver prices fell modestly amid discussions on Iran's military readiness and the upcoming release of the Bank of Japan's policy meeting minutes.

2026. g. 27. sept. 23:01 UTC

Macro News

The AUD/USD is slightly lower as trading resumes, positioned near the lower end of its one-month range amid upcoming Bank of Japan minutes.

2026. g. 27. sept. 23:01 UTC

Macro News

Oil (WTI) is advancing modestly as tensions in the Middle East escalate, with Iran signaling a potential disruption to global oil supply routes.

2026. g. 27. sept. 23:01 UTC

Correlated Moves
Macro News

Gold prices fell modestly, continuing a downward trend as geopolitical tensions and expectations of Bank of Japan minutes weigh on the market.

2026. g. 27. sept. 23:01 UTC

Correlated Moves
Macro News

Platinum prices are declining, continuing a downward trend influenced by silver's drop and geopolitical tensions affecting global energy markets.

2026. g. 27. sept. 23:01 UTC

Correlated Moves
Macro News

The Dow Jones Index is lower amid mixed U.S. equities, influenced by U.S.-China tariff discussions and geopolitical concerns over Iran.

2026. g. 27. sept. 23:01 UTC

U.S. Wholesale Inventories Expected to Rise 1.1% in August, Indicating Strong Business Confidence Amid Economic Uncertainties

2026. g. 27. sept. 23:01 UTC

U.S. GDP Growth Rate for Q2 2026 Forecasted at 1.6% Amid Positive Foreign Investment and Trade Developments Ahead of September Release.

2026. g. 27. sept. 23:01 UTC

U.S. GDP Price Index QoQ Final for Q2 2026 set to release on September 30, with a forecasted increase of 0.064%, amid positive market sentiment from U.S.-China trade negotiations aimed at reducing tariffs.

2026. g. 27. sept. 23:01 UTC

PCE Price Index MoM for August 2026 set to release on September 30, with market expecting a 0.4% increase amid fluctuating inflation trends and rising foreign investment in U.S. equities.

2026. g. 27. sept. 23:01 UTC

Upcoming PCE Price Index Release on September 30, 2026, May Influence U.S. Inflation Trends and Federal Reserve Policy Amid Mixed Market Sentiment.

2026. g. 27. sept. 23:01 UTC

Personal Income MoM Data for August 2026 Forecasted to Rise by 0.4%, Indicating Cautious Optimism in U.S. Economic Growth Ahead of Release on September 30.

Salīdzinājums

Cenas izmaiņa

Microbot Medical Inc Prognoze

Cenas mērķis

By TipRanks

396.73% augšup

Prognoze 12 mēnešiem

Vidējais 6.333 USD  396.73%

Augstākais 12 USD

Zemākais 3 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

3

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.